If there is moderate to severe panhypoproteinemia with PLE, what is the recommended initial step?

• A. Monitor and recheck later
• B. Start broad-spectrum antibiotics
• C. Biopsy early
• D. Proceed with dietary trial

Answer: (C)

In moderate to severe panhypoproteinemia with protein-losing enteropathy, the priority is to identify the underlying cause because PLE can arise from several distinct gut diseases, and treatment hinges on the exact pathology. Early intestinal biopsy provides histopathology that can distinguish conditions such as lymphangiectasia, inflammatory enteropathy, or neoplasia, which noninvasive tests or empirical management can’t reliably separate. Knowing the specific lesion guides targeted therapy: lymphangiectasia often responds to a specialized diet and fat modulation, inflammatory conditions may require immunosuppressants, and neoplasia would lead to oncologic approaches. While supportive care is important to manage low protein levels, delaying a diagnostic biopsy risks ongoing protein loss and progression of disease. So obtaining a biopsy promptly offers the clearest path to a precise diagnosis and appropriate treatment.